Squamous cell carcinoma of the gingival mucosa (oral cancer)

  • Synonyms: Gingival squamous cell carcinoma
  • Occurrence: rarer
  • Location of disease: Head/Neck
Author: Dr. med. vet. Gisa Löwe | Last modified: 29.09.2025
Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Gingival squamous cell carcinoma in dogs is a malignant epithelial tumor that originates from the mucosal surface at the gum line, in the spaces between teeth, or on the free and attached gingiva.

In many cases, the tumor infiltrates the underlying alveolar bone socket early on (alveolar bone is the bone that supports the teeth), which explains typical “periodontal” symptoms such as tooth mobility or jaw swelling.

The most important facts at a glance

Gingival squamous cell carcinoma in dogs is a locally highly invasive epithelial tumor of the oral cavity that affects the jawbone early on, causing characteristic symptoms such as bleeding gums, bad breath, pain, eating problems, and tooth mobility. Diagnosis is based on a thorough examination of the oral cavity under sedation, dental X-rays, and especially CT to assess the extent. Furthermore, histopathological confirmation by incisional biopsy and staging, a lymph node fine-needle biopsy, and thorax imaging are necessary. Therapeutically, resection with tumor-free margins, sometimes with the removal of the upper or lower jaw (mandibulectomy/maxillectomy), is the most effective therapy for local control; radiation therapy supplements or replaces therapy in non-operable situations. Anti-inflammatory drugs and pain therapy are important supportive measures during therapy. The prognosis is overall more favorable than that of tonsillar SCC, but depends heavily on tumor size, location, margin status, and lymph node involvement; local recurrence is the most common complication. Consistent follow-up care at short intervals in the first few months, then lifelong at longer intervals, serves to detect recurrence and control symptoms. True primary prevention does not exist; early diagnosis through regular inspection, professional dental prophylaxis, and consistent biopsy of suspicious lesions is therefore the most practical way to improve the chances of recovery. Research is working on more precise N-staging, minimally invasive local therapies, and molecularly targeted drugs; in the future, individualized concepts with a better balance of tumor control and quality of life could emerge.

Causes

A single triggering cause is not known; rather, it is a multicausal event. Chronic inflammatory conditions and repeated mechanical irritation seem to support the development of squamous cell carcinoma. Chronic periodontitis, constant ulcerative inflammation of the oral mucosa, or malalignments with trauma to the gums (the gingiva) can also theoretically increase the likelihood of developing squamous cell carcinoma (SCC), even though the vast majority of dogs with periodontal diseases do not develop SCC.

Genetic predispositions for oral tumors in general are likely in dogs, but clear breed-specific risks are less pronounced than, for example, in oral melanoma; nevertheless, medium to large breeds in middle to older age are overrepresented.

Metastasis occurs preferentially via the lymphatic route (lymphogenous) into regional lymph nodes, and less frequently via the bloodstream (hematogenous) into the lungs. Overall, the distant metastasis rate for oral SCC (oral cancer) not originating from the tonsils is lower than its local aggressiveness would suggest.

Symptoms

Rare symptoms:

Patients often show a combination of a visible oral mass, unpleasant bad breath (halitosis), heavy salivation (hypersalivation, often bloody), pain when eating, preference for soft food, sudden dropping of food, bleeding gums, loosening or loss of individual teeth, and jaw swelling. In the case of tumors in the upper jaw, breakthrough into the nasal cavity can lead to one-sided nasal discharge, sneezing, or watery eyes (epistaxis); extensive lesions can lead to an open connection between the oral cavity and the nasal cavity (oronasal fistula). Regional lymph nodes are often enlarged, frequently as a reaction to the inflammation, sometimes also as a spread of the cancer (metastatic). In advanced cases, pathological jaw fractures, trismus (restricted mouth opening), or, if the tumor penetrates the orbital cavity, symptoms such as watery eyes or protrusion of the eyeball are a threat. General symptoms such as weight loss and inappetence often result secondarily from pain and refusal to eat due to pain when eating.

 

Diagnosis

Diagnosis is based on medical history and clinical examination, imaging procedures, histological examination of tissue samples, and oncological staging. The gold standard for preoperative assessment of spread is computed tomography (CT) of the head and neck. CT shows bone and soft tissue with a precise representation of the extent and direction, bone involvement, and the relationship to the nasal cavity and other structures in this region. If invasion into the orbital cavity (orbit) or the base of the skull is suspected, magnetic resonance imaging (MRI) may be useful as a supplement (explanation: MRI shows soft tissues particularly well).

Therapy

The main therapeutic pillar is surgical removal with the widest possible safety margins, supplemented depending on the case by radiation therapy, chemotherapy, electrochemotherapy, or immunomodulatory approaches. The choice is based on location, size, depth of invasion, lymph node status, general condition, and the goals of the owners (curative vs. palliative). Consistent pain therapy is mandatory (perioperative opioids, NSAIDs, possibly gabapentin as things progress). Antibiotics are used for a short time in ulcerative, necrotic tumors or after extensive procedures. Careful nutritional support is important; many dogs compensate for a partial removal of the lower jaw (mandibulectomy) with surprisingly good long-term well-being, but benefit initially from soft, high-energy, and high-protein food. Oral hygiene should be carefully rebuilt postoperatively to minimize secondary infections.

Prognosis and follow-up care

The prognosis for gingival SCC is significantly better than that of other malignant oral tumors when consistent local therapy is applied. Decisive prognostic factors are tumor size and location, extent of bone invasion, resection margin status, lymph node involvement, and the histological degree of differentiation. SCC in the upper jaw with penetration into the nasal or orbital cavity is more difficult to remove and more likely to recur. Radiation therapy can achieve local control even without resection, although long-term results are on average somewhat weaker than those after radical surgery with clear margins. Distant metastases to the lungs occur less frequently than local recurrence, but should be considered at every follow-up. Structured follow-up care increases the chance of detecting and treating recurrences early. A check-up every 8–12 weeks in the first 6–12 months, then every 3–6 months, and at least every six months in the long term has proven effective.

Prevention

True prevention in the sense of preventing tumor development is currently not possible, as clear avoidable risk factors have not been proven. Nevertheless, the chance of early diagnosis can be increased: regular oral cavity examinations as part of prophylaxis, professional dental cleanings with thorough inspection under anesthesia if necessary, and a low threshold for biopsy for any persistent gingival growth or ulceration that lasts longer than two to three weeks. Good home oral hygiene reduces chronic inflammation and makes it easier to recognize new lesions. Exposure to secondhand smoke and other potential toxins should be avoided, even if the data situation is not clear.

Outlook on current research

Current research on oral cancer in dogs (squamous cell carcinoma of the gums) is basically working on three areas: better local treatments, more accurate diagnoses, and new, targeted drugs. For local treatments, gentler procedures are being added, such as electrochemotherapy. In this process, a tumor is treated with a low electrical pulse and a cancer drug so that the agent can better penetrate the cancer cells. Studies are currently testing how well this works for tumors that have already grown into the jawbone and whether the combination with radiation therapy brings additional benefits.

For diagnostics, the goal is to detect or rule out metastases in lymph nodes more reliably. Here, the concept of the so-called sentinel lymph node is used: this is the first lymph node into which cancer cells would migrate from the tumor site. It is tracked down with a small amount of marking substance and specifically examined during surgery. This makes it easier to decide whether and to what extent lymph nodes need to be treated – unnecessary procedures can be avoided, while necessary ones can be carried out in good time.

At the level of molecular target structures, researchers are trying to find out which switches in the cancer cells drive growth. In dogs, EGFR, COX-2, p53, and PD-L1, among others, are being examined more closely. The hope is to be able to direct drugs specifically against such switches, similar to what is known from human medicine. Well-planned studies must show whether this is effective and safe before such therapies become routine.

New possibilities for monitoring the course of the disease are also exciting. These include blood tests for free-circulating tumor DNA (often called liquid biopsy). The goal is to detect relapses earlier or to assess the response to a treatment promptly without the need for major procedures or complex imaging every time. The digital evaluation of tissue samples using artificial intelligence is also being tested. For example, it could help to assess surgical margins even more reliably as “tumor-free” or “not tumor-free.”

Finally, the quality of life of the dogs is moving more into focus. For this purpose, standardized questionnaires and assessment scales are being developed, which are used specifically after major jaw operations. Among other things, eating behavior, pain, social behavior, and long-term adaptation in everyday life are queried. Such data, supplemented by feedback from the owners, should help veterinarians plan treatment paths even more individually and truly oriented towards the well-being of the individual animal.

Frequently asked questions (FAQs)

1. How does gingival squamous cell carcinoma differ from tonsillar?
– Gingival SCC is primarily locally invasive and metastasizes less early; tonsillar has a high tendency to metastasize and a less favorable prognosis. -
2. Is the tumor painful?
– Yes, typically, due to ulceration, inflammation, and bone invasion. Effective pain management is a central part of the treatment. -
3. Does bone always have to be removed?
– If bone invasion is proven, yes, otherwise there is a high risk of recurrence. The incision is planned based on the CT extent. -
4. How well do dogs cope with a partial mandibulectomy?
– Usually surprisingly well. Initially, loss of saliva, tongue protrusion, and food spilling occur, but most animals adapt within a few weeks and show a good quality of life. -
5. Is radiation therapy alone enough?
– In selected cases, definitive radiation therapy can achieve local control, especially if R0 resection is not possible. For very large, bone-invasive tumors, the combination of surgery and radiation is often superior. -
6. Do chemotherapy drugs work?
– Systemic chemotherapy shows only limited response rates in non-tonsillar oral SCC and is mostly used palliatively or adjuvantly with specific objectives. -
7. Should lymph nodes be removed preventively?
– General prophylactic lymphadenectomy is not standard. Cytological clarification via FNA and selective removal of suspicious nodes are common practice; sentinel mapping is being established. -
8. How often are follow-up checks necessary?
– In the first 6–12 months primarily every 8–12 weeks, then every 3–6 months, and in the long term every six months. Imaging according to findings and symptoms. -
9. Are there "gentle" alternatives to major surgery?
– Palliative radiation, electrochemotherapy, and photodynamic procedures can alleviate symptoms and partially reduce tumor volume, but rarely replace oncological resection when the goal is curative. -
10. Can I prevent it by brushing teeth?
– Brushing teeth does not prevent SCC, but it can reduce inflammation and help to notice changes early. Any persistent growth should be biopsied.